跳至主要内容
临床试验/NCT05958329
NCT05958329已完成不适用

Remote Short Sessions of Heart Rate Variability Biofeedback

Icahn School of Medicine at Mount Sinai1 个研究点 分布在 1 个国家目标入组 127 人开始时间: 2021年7月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
127
试验地点
1
主要终点
Heart Rate Variability

研究概览

简要总结

Remote 5 minute sessions of heart rate variability (HRV) biofeedback will be employed by participants for 5 weeks. Subjects will be followed for a total of 17 weeks. Surveys assessing psychological well being will be completed during the study period. Wearable devices will be worn to monitor HRV response during the study period.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Participants were recruited from The Mount Sinai Hospital, Morningside Hospital, Mount Sinai West, Mount Sinai Beth Israel, Mount Sinai Queens, New York Eye and Ear Infirmary, and Mount Sinai Brooklyn.
  • •Eligible participants were 18 years of age or greater.
  • •Had an iPhone series 5 or greater.
  • •Had or were willing to wear an Apple Watch 4 or greater.
  • •Potential participants were excluded if they had an underlying chronic disease or used a medication that is known to impact autonomic nervous system function.

排除标准

  • •Underlying chronic diseases including but not limited to:
  • •rheumatoid arthritis
  • •systemic lupus erythematosus
  • •inflammatory bowel disease
  • •Use of medications that impact heart rate variability including but not limited to:
  • •beta-blockers (ie. atenolol, carvedilol, metoprolol, Coreg, Tenormin, Normodyne, Trandate)
  • •calcium channel blockers (ie. Norvasc, amlodipine, Cardene, nicardipine, Procardia, nifedipine, Cardizem, diltiazem)
  • •regularly used benzodiazepines

研究组 & 干预措施

HRV Biofeedback

Experimental

5 minute daily sessions of HRV biofeedback

干预措施: HRV Biofeedback (Behavioral)

结局指标

主要结局

Heart Rate Variability

时间窗: Up to Week 7

Heart rate variability measured in milliseconds (ms) at 7 weeks compared to baseline. Higher rates indicate increased parasympathetic nervous system activity.

次要结局

  • Connor-Davidson Resilience Scale (CD-RISC(Up to Week 17)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Robert Hirten

Associate Professor

Icahn School of Medicine at Mount Sinai

研究点 (1)

Loading locations...

相似试验

Short Sessions of HRV Biofeedback | 临床试验